Kristine Peers

Strong believer in Europe and hopeful for sustainable innovative healthcare; tweets represent my own opinion

[Damiano de Felice @damidefelice]

Emer Cooke explains that @EMA_News is willing to prioritize the regulatory processes of much-needed, new #antibiotics. She also highlights, though, that innovation is not coming through. She calls for more funding to support #push and #pull incentives.

@EU2024BE #ConfAMR24

[Belgium in the EU @BelgiuminEU]

🦠 #EU2024BE organises the Antimicrobial Resistance (#AMR) Conference from 6 to 8 May.

📎 Read our policy brief on strengthening EU's response to the prevention and control of AMR: https://t.co/e8N7ENfeUU

Let's work together to combat AMR and ensure a healthier future for all!

[AMR Action Fund @AMRActionFund]

"Without a commitment to continuous, sustainable financing for innovation, we will struggle to keep up with bacteria which we know are constantly evading not only our tools, but also outpacing our knowledge and our expertise." -Director of International Policy @deepalimpatel during a @UNEP @WHO @FAO @WOAH call for action on #AMR.

[Prof. Dame Sally Davies @DameSallyDavies]

Tackling AMR needs scientists, policy-makers, and the public to work together.

Thank you to the researchers out there focusing on new antibiotics.

And thank you to @AMRAlliance for putting a spotlight on the need for many, many more.

[European Observatory on Health Systems & Policies @OBShealth]

#EPH2023 sees global experts tackle #AMR resistance & what countries can do to combat it👇

Join this session in Liffey Hall 2 at 11:40 w/ @dimitrapanteli @Dlofowong @KPleuven & more! #OBSatEPH

🔎 Find the topic covered in our policy brief w/ @SwedeninEU https://t.co/WwpVDnEx8Q

[Thomas Allvin @ThomasAllvin]

Nathalie Moll @NathalieMoll - the industry supports cross-country collaborations if they lead to better and faster access for patients #POLITICOHealthcare

[AMR Action Fund @AMRActionFund]

If antibiotics stop working, once curable infections could become fatal.

In the film #RaceAgainstResistance, we get to know our first line of defense against superbugs! Visit https://t.co/9dYsLrxstQ to watch it now and hear how they're working to combat the rise of #AMR.

[Damiano de Felice @damidefelice]

The global efforts to #StopSuperbugs, including our work at @CARB_X, are the #BigRead on today's edition of @FT.

https://t.co/HXDvHYqu8R

#AMR #AMRSOS @TimothyJinks1 @JohnRex_NewAbx @UKAMREnvoy @LouiseNS @bishen_shyam @findingpneumo @joeldenis10 @Beth_Thompson @JeremyFarrar

[AMR Action Fund @AMRActionFund]

"The real #AMR challenge, though, is perhaps not the science but the lack of market incentive," writes @anjahuja in a new @FT column https://t.co/STh18ah6ud

[AMR Action Fund @AMRActionFund]

Can you imagine a world where antibiotics and other antimicrobials stopped working?

Premiering September 5th, the film #RaceAgainstResistance dives into one of humanity’s biggest existential threats—and shows us what it will take to avert a disaster.

[Kristine Peers @KPleuven]

@ThomasAllvin Did you see it on IMAX?

[Kristine Peers @KPleuven]

With the upcoming review of the General Pharmaceutical Legislation, the EU has the opportunity to help address the issue of AMR and position the EU as hub of antimicrobial and policy innovation. #AMR #AMRActionFund #EFPIA #innovation

[AMR Action Fund @AMRActionFund]

"In just about every other therapeutic area, investors and drugmakers can rely on the market to reward the development of impactful medicines through strong sales," writes @deepalimpatel. "Not so with antimicrobials." #AMR https://t.co/AxdTh2DQV4 via @EFPIA

[AMR Action Fund @AMRActionFund]

"In just about every other therapeutic area, investors and drugmakers can rely on the market to reward the development of impactful medicines through strong sales," writes @deepalimpatel. "Not so with antimicrobials." #AMR https://t.co/AxdTh2DQV4 via @EFPIA

[AMR Action Fund @AMRActionFund]

“Bacterial and fungal pathogens will continually evolve resistance to new treatments, and the world needs meaningful incentives for a sustainable ecosystem of innovation to flourish,” writes @deepalimpatel #AMR https://t.co/AxdTh2Dj5w

[AMR Action Fund @AMRActionFund]

There’s no quick fix to antimicrobial resistance. But smart policies that encourage innovation and investment could give us a fighting chance against superbugs. #AMR https://t.co/qEB2fwQ2u7

[Damiano de Felice @damidefelice]

Malin Grape, #AMR Ambassador for Sweden, emphasizes the importance of investing in antibacterial R&D and diversifying scientific approaches (from new drug classes to non-traditional therapeutics) at the #STOAevent on "Tackling Antimicrobial Resistance: from science to policy."

[Nathalie Moll @NathalieMoll]

For more information on our cross organisation research initiative called #Moonshot for #rarediseases to overcome the complexities of the scientific challenges at the root of rare diseases read here:
👉🏻 https://t.co/vHShZtHV45
@EFPIA
#wewontrest

[BEAM Alliance @AllianceBEAM]

Killer question: Is there any hope for the return of investors in the #antimicrobialresistance field? To find out more, join our dedicated session at the 7th @AMRConference. Register here: https://t.co/eNs4Ux721Q

[AMR Action Fund @AMRActionFund]

“I personally find it unacceptable that we would have drugs in hand that help a significant number of patients from not passing away — and we have to drop this for financial reasons, rather than scientific ones.” The unfortunate reality of the abx market
https://t.co/SCDmWccbtB

[BEAM Alliance @AllianceBEAM]

Our reflection paper on pull incentives identifies key criteria for the mechanism to be effective. Delinking revenues from sales and predictability are just two among many.

To see how the mechanism can address the broken AMR market, read our paper: https://t.co/AOnc0ccLq7